Well if you’re a medic and understand data then you’ll understand the problems inherent in comparing arms from different trials and drawing the sorts inferences that are being drawn. I’m not saying there’s anything wrong with LuPIN per se. Have Kinghorn explicitly stated LuPIN trial proves adding Nox drug to Lu is superior to Lu alone? Not that I’ve seen.
- Forums
- ASX - By Stock
- NOX
- LuPIN abstract
LuPIN abstract, page-16
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NOX (ASX) to my watchlist
(20min delay)
|
|||||
Last
11.0¢ |
Change
0.014(14.6%) |
Mkt cap ! $32.14M |
Open | High | Low | Value | Volume |
9.2¢ | 11.5¢ | 9.2¢ | $53.30K | 518.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 48681 | 10.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
11.0¢ | 74195 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 48681 | 0.100 |
1 | 7253 | 0.099 |
2 | 23340 | 0.092 |
1 | 10989 | 0.091 |
3 | 204710 | 0.090 |
Price($) | Vol. | No. |
---|---|---|
0.110 | 69808 | 3 |
0.115 | 256630 | 6 |
0.120 | 61648 | 3 |
0.125 | 447472 | 6 |
0.130 | 199760 | 1 |
Last trade - 15.45pm 23/08/2024 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online